http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S56128774-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_204ea9f0f83d1c51a916e46a41a6a14a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-465
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-02
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
filingDate 1980-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6e8323bfadb9a8d977d0f7712a0cabc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e7f835bf519397a6ddb7c6ed6560ec5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fef8c9cb766bafd47f19c127ed69696
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cc8c532f23ec9a96265116bf431ba70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_539818fce596ac21edbf6dd773d74c68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92b5dbdbb2968008aeb158620c8ee760
publicationDate 1981-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S56128774-A
titleOfInvention New physiologically active substance ebelactone and its preparation
abstract NEW MATERIAL:Ebelactone A or ebelactone B expressed by the formula (R is CH 3 or CH 3 -CH 2 -). n USE: An immunity enhancing agent, having antiesterase and antiformylmethionine aminopeptidase activity, further an anti-inflammatory action and an enhancing action on a carcinostatic substance. n PROCESS: A microorganism capable of producing ebelactone which belongs to the genus Streptomyces, e.g. Streptomyces MG7-G1 strain (FERM-P NO. 5363) belonging to the genus Streptomyces, is cultivated to produce and accumulate the ebelactone in the culture fluid, and the ebelactone is collected therefrom. n COPYRIGHT: (C)1981,JPO&Japio
priorityDate 1980-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426107067

Total number of triples: 29.